A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Monday, March 6 - Tuesday, March 7 | Washington, DC & Virtual Innovations in the diagnostic specialties have the potential to dramatically reshape cancer diagnosis and enable precision therapy. Spurred […]
Tuesday, March 7 | 8-9 a.m. ET | Online This short webinar series is presented by a team from Qatar Biobank and will explore the journey of Qatar Biobank from […]
GMKB